0 Comments
0 Shares
389 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Alzheimer's Disease Diagnostic Market: How Is the Alzheimer's Diagnostic Market Being Transformed by New Treatments?FDA-approved amyloid-targeting therapies — lecanemab (Leqembi) and donanemab (Kisunla) receiving FDA approval for early AD treatment — have fundamentally transformed Alzheimer's diagnostics from a primarily academic exercise toward a clinically necessary component of treatment pathway qualification, with the Alzheimer's Disease Diagnostic Market reflecting the treatment-driven...0 Comments 0 Shares 304 Views 0 Reviews
-
Alzheimer's Disease Therapeutics Market: Pipeline Drugs, Biomarker Innovation, and Market Size Forecast"Competitive Analysis of Executive Summary Alzheimer’s Disease Market Size and Share Data Bridge Market Research analyzes that the Alzheimer’s disease market which was USD 5.10 billion in 2022, is likely to reach USD 9.73 billion by 2030, and is expected to undergo a CAGR of 8.40% during the forecast period. To stand apart from the competition, a careful idea about the...0 Comments 0 Shares 920 Views 0 Reviews
-
Alzheimer’s Disease Diagnostic Market Key Manufacturers: Leading Players and StrategiesThe Alzheimer’s Disease Diagnostic Market Key Manufacturers include Roche, GE Healthcare, Siemens Healthineers, Eli Lilly, and Biogen. These companies dominate due to strong R&D capabilities, broad distribution networks, and robust product portfolios. Imaging solutions, biomarker assays, and AI-assisted diagnostics remain core revenue drivers. Key manufacturers are focusing on...0 Comments 0 Shares 1K Views 0 Reviews
-
Alzheimer’s Disease Diagnostic Market: How Is the Brazil Public‑Health System Catching Up in the Alzheimer’s Disease Diagnostic Market?Brazil’s aging population is reshaping the Alzheimer’s Disease Diagnostic Market, as rising dementia prevalence drives demand for earlier, more accurate diagnostic tools. Alzheimer’s Disease Diagnostic Market Growing dementia burden and late‑diagnosis gap Millions of Brazilians live with Alzheimer’s or related dementias, yet many cases are diagnosed only at...0 Comments 0 Shares 134 Views 0 Reviews
-
Alzheimer’s Disease Market Size & Future Forecast"Executive Summary Alzheimer’s Disease Market Trends: Share, Size, and Future Forecast Data Bridge Market Research analyzes that the Alzheimer’s disease market which was USD 5.10 billion in 2022, is likely to reach USD 9.73 billion by 2030, and is expected to undergo a CAGR of 8.40% during the forecast period. The Alzheimer’s Disease Market report...0 Comments 0 Shares 946 Views 0 Reviews
-
Alzheimer’s Disease Treatment Market Analysis and Growth Outlook"What’s Fueling Executive Summary Alzheimer’s Disease Treatment Market Market Size and Share Growth Data Bridge Market Research analyses that the Alzheimer’s disease treatment will exhibit a CAGR of around 8.79% for the forecast period of 2022-2029. To stand apart from the competition, a careful idea about the competitive landscape, their product range, their...0 Comments 0 Shares 1K Views 0 Reviews
-
Electro-Medical Devices in Alzheimer’s Treatment Market Research Report: Industry Trends & OpportunitiesKey Drivers Impacting Executive Summary Electro-Medical Devices in Alzheimer's Treatment Market Size and Share The global electro-medical devices in Alzheimer's treatment market size was valued at USD 4.99 billion in 2024 and is expected to reach USD 10.66 billion by 2032, at a CAGR of 9.95% during the forecast period The report explains the vital developments about the...0 Comments 0 Shares 159 Views 0 Reviews
-
North America Alzheimer's Drugs Market Analysis and Forecast 2031The rising burden of Alzheimer’s disease across the United States, Canada, and Mexico is accelerating demand for advanced therapeutics, innovative biologics, and early-stage treatment solutions. Increasing life expectancy and the expanding geriatric population are contributing to a higher prevalence of neurodegenerative disorders, encouraging pharmaceutical companies to strengthen...0 Comments 0 Shares 21 Views 0 Reviews
-
Rising Challenges and Opportunities in the Dementia–Alzheimer’s Disease Market and Forecast to 2030Data Bridge Market Research analyses that the market, which was USD 13,000.00 million in 2022, would rocket up to USD 25,000.00 million by 2030 and is expected to undergo a CAGR of 8.5% during the forecast period. Dementia, with Alzheimer’s disease as its most prevalent form, continues to emerge as one of the most pressing global health challenges. Characterized by progressive cognitive...0 Comments 0 Shares 1K Views 0 Reviews
-
The "Neurological" Horizon: How 2026 is Using "Hot" Molecules to Treat Alzheimer's.In late 2026, the industry is pivoting toward "Neuro-Theranostics." While oncology remains the anchor, a radical new class of "Amyloid-Clearing Radiopharmaceuticals" has entered Phase 2 trials, aiming to use targeted radiation to break down the plaques associated with Alzheimer's disease. This innovation is a primary driver for the market, as it promises to treat the brain with...0 Comments 0 Shares 508 Views 0 Reviews
-
Global Neuroprotective Agents Market Growing at 7.1% CAGR Through 2034According to a new report from Intel Market Research, the global Neuroprotective Agents Market was valued at USD 5.8 billion in 2025 and is projected to grow from USD 6.3 billion in 2026 to USD 10.9 billion by 2034, exhibiting a robust CAGR of 7.1% during the forecast period (2026–2034). This growth is propelled by the escalating burden of neurodegenerative diseases, a rapidly aging...0 Comments 0 Shares 185 Views 0 Reviews
-
Memantine Market Growth Analysis and Revenue ForecastThe increasing prevalence of neurological disorders, particularly Alzheimer’s disease and dementia, is significantly driving the growth of the global memantine industry. Growing awareness regarding cognitive health, rising geriatric population, and increasing demand for effective neurodegenerative disease treatments are contributing to market expansion worldwide. Pharmaceutical companies...0 Comments 0 Shares 22 Views 0 Reviews
More Results
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek